December 18, 2017 / 10:51 AM / a year ago

BRIEF-OncoArendi Therapeutics Plans To Debut On WSE

Dec 18 (Reuters) - ONCOARENDI THERAPEUTICS (OAT) IPO-ORT.WA:

* A BIOTECHNOLOGY COMPANY ONCOARENDI THERAPEUTICS IPO-ORT.WA HAS SUBMITTED AN IPO PROSPECTUS TO THE POLISH FINANCIAL SUPERVISION AUTHORITY (KNF), THE COMPANY SAID IN A STATEMENT

* THE COMPANY PLANS TO ISSUE NEW SHARES VIA PUBLIC OFFERING AND DEBUT ON THE MAIN MARKET OF THE WARSAW STOCK EXCHANGE (WSE)

* THE COMPANY’S CEO AND CO-FOUNDER, MARCIN SZUMOWSKI, EYES THE DEBUT IN THE FIRST HALF OF 2018

* FROM THE IPO PROCEEDS PLANS TO FINANCE ITS CURRENTLY UNDERTAKEN R&D PROJECTS AND TO FUND NEW PROJECTS

* OAT DEDICATES ITSELF TO DISCOVERING, DEVELOPING AND COMMERCIALIZING NOVEL THERAPEUTICS FOR NEOPLASTIC AND INFLAMMATORY DISEASES

Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below